TipRanks
Go Ultimate55% OFF

Compare Lakefront Biotherapeutics NV (GLPGN) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
MX:GLPGNLakefront Biotherapeutics NV$40.12B3.91―Moderate SellUnlock the MX:GLPGN analyst price target with TipRanks PremiumMX:GLPGNUnlock the MX:GLPGN top-analyst price target with TipRanks Premium
NL:PHARMPharming GroupEUR 1.09EUR 771.13M34.56-3.88%―Unlock the NL:PHARM analyst price target with TipRanks PremiumMX:GLPGN vs NL:PHARMUnlock the NL:PHARM top-analyst price target with TipRanks Premium
NL:VVYVivoryon Therapeutics AGEUR 0.80EUR 23.75M-3.49-50.80%―Unlock the NL:VVY analyst price target with TipRanks PremiumMX:GLPGN vs NL:VVYUnlock the NL:VVY top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
MX:GLPGNLakefront Biotherapeutics NV―――
NL:PHARMPharming Group1.09-0.04-3.63%
NL:VVYVivoryon Therapeutics AG0.80-0.84-51.04%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts